WELL Health Technologies 관리

관리 기준 확인 3/4

WELL Health Technologies CEO는 Hamed Shahbazi, May2018 에 임명되었습니다 의 임기는 6.83 년입니다. 총 연간 보상은 CA$ 6.51M, 7.7% 로 구성됩니다. 7.7% 급여 및 92.3% 보너스(회사 주식 및 옵션 포함). 는 € 49.42M 가치에 해당하는 회사 주식의 5.93% 직접 소유합니다. 49.42M. 경영진과 이사회의 평균 재임 기간은 각각 5.9 년과 6.9 년입니다.

주요 정보

Hamed Shahbazi

최고 경영자

CA$6.5m

총 보상

CEO 급여 비율	7.7%
CEO 임기	6.8yrs
CEO 소유권	5.9%
경영진 평균 재임 기간	5.9yrs
이사회 평균 재임 기간	6.9yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Hamed Shahbazi 의 보수는 WELL Health Technologies 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	CA$73m
Jun 30 2024	n/a	n/a	CA$147m
Mar 31 2024	n/a	n/a	CA$30m
Dec 31 2023	CA$7m	CA$500k	CA$82k
Sep 30 2023	n/a	n/a	-CA$7m
Jun 30 2023	n/a	n/a	-CA$4m
Mar 31 2023	n/a	n/a	-CA$5m
Dec 31 2022	CA$2m	CA$450k	CA$1m
Sep 30 2022	n/a	n/a	-CA$29m
Jun 30 2022	n/a	n/a	-CA$37m
Mar 31 2022	n/a	n/a	-CA$45m
Dec 31 2021	CA$5m	n/a	-CA$44m
Sep 30 2021	n/a	n/a	-CA$29m
Jun 30 2021	n/a	n/a	-CA$21m
Mar 31 2021	n/a	n/a	-CA$9m
Dec 31 2020	CA$710k	n/a	-CA$4m
Sep 30 2020	n/a	n/a	-CA$9m
Jun 30 2020	n/a	n/a	-CA$10m
Mar 31 2020	n/a	n/a	-CA$8m
Dec 31 2019	CA$681k	n/a	-CA$8m
Dec 31 2018	CA$502k	n/a	-CA$2m

보상 대 시장: Hamed 의 총 보상 ($USD 4.53M )은 German 시장( $USD 1.43M ).

보상과 수익: Hamed 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Hamed Shahbazi (49 yo)

6.8yrs

테뉴어

CA$6,508,755

보상

Mr. Hamed Shahbazi, B. Sc., serves as Chairman & Chief Executive Officer at WELL Ventures. He is Chairman of the Board of Healwell AI Inc. from February 2024. He was Director of Healwell AI Inc. from Octob...

리더십 팀

이름	위치	테뉴어	보상	소유권
Hamed Shahbazi	Founder	6.8yrs	CA$6.51m	5.93% € 49.4m
Eva Fong	Chief Financial Officer	5.9yrs	CA$1.15m	0.72% € 6.0m
Amir Javidan	Chief Operating Officer	6.2yrs	CA$1.12m	0.81% € 6.7m
James Kreger	CEO of WELL Health USA & CRH Medical	3.2yrs	CA$1.64m	데이터 없음
Beemal Shah	COO of CRH Medical Corporation	2.5yrs	CA$1.58m	데이터 없음
Pardeep Sangha	Vice President of Corporate Strategy & Investor Relations	5.9yrs	데이터 없음	데이터 없음
Brian Levinkind	Senior Vice President of Corporate Development	5.9yrs	CA$302.30k	데이터 없음
Chris Ericksen	Senior Vice President of Strategic Partnerships & Marketing	6.2yrs	데이터 없음	데이터 없음
Shane Sabatino	Chief People Officer	4.2yrs	데이터 없음	데이터 없음
Michael Frankel	Chief Medical Officer	6.3yrs	CA$639.73k	데이터 없음
Michael Goodman	Head of Acquisitions - Eastern Canada	4.7yrs	데이터 없음	데이터 없음
Iain Paterson	Chief Information Security Officer	2.8yrs	데이터 없음	데이터 없음

5.9yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: W7V 의 관리팀은 노련하고 경험 (평균 재직 기간 5.9 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Hamed Shahbazi	Founder	9yrs	CA$6.51m	5.93% € 49.4m
Thomas Liston	Independent Director	6.9yrs	CA$257.87k	0.26% € 2.2m
Kenneth Cawkell	Independent Director	9yrs	CA$245.50k	0.19% € 1.6m
John Kim	Independent Director	7.1yrs	CA$245.50k	0.16% € 1.3m
Patricia Kirkpatrick	Member of Advisory Board	5.5yrs	데이터 없음	데이터 없음
Tara McCarville	Independent Director	4.9yrs	CA$245.50k	0.047% € 388.9k
Sybil E. Lau	Independent Director	2.6yrs	CA$210.24k	0.22% € 1.8m

6.9yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: W7V 의 이사회는 경험(평균 재직 기간 6.9 년)으로 간주됩니다.

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2025/03/17 05:08
장 마감 주가	2025/03/14 00:00
수익	2024/09/30
연간 수익	2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처는 미국 증권의 예를 사용했습니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 Github에서 확인할 수 있습니다.

애널리스트 출처

WELL Health Technologies Corp. 17 애널리스트 중 14 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Gabriel Leung	Beacon Securities Limited
Douglas Taylor	Canaccord Genuity
Scott Fletcher	CIBC Capital Markets

WELL Health Technologies 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Independent Director recently sold €112k worth of stock

Independent Director recently sold €267k worth of stock

Independent Director recently sold €116k worth of stock

WELL Health Technologies Corp. Announces Appointment of Sybil Lau to its Board of Directors

WELL Appoints Iain Paterson to the Position of Chief Information Security Officer

Recent updates

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Microquest Inc

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

Investor sentiment improves as stock rises 17%

New minor risk - Share price stability

Third quarter 2024 earnings released: CA$0.33 loss per share (vs CA$0.032 loss in 3Q 2023)

WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Second quarter 2024 earnings released: EPS: CA$0.45 (vs CA$0.024 loss in 2Q 2023)

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Investor sentiment improves as stock rises 16%

New major risk - Revenue and earnings growth

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

First quarter 2024 earnings released: EPS: CA$0.062 (vs CA$0.062 loss in 1Q 2023)

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

New minor risk - Share price stability

Third quarter 2023 earnings released: CA$0.032 loss per share (vs CA$0.019 loss in 3Q 2022)

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

Independent Director recently sold €112k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.

Second quarter 2023 earnings released: CA$0.024 loss per share (vs CA$0.027 loss in 2Q 2022)

WELL Health Technologies Corp. to Report Q2, 2023 Results on Aug 10, 2023

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc.

Well Health Technologies Corp. Provides Revenue Guidance for the Year 2023

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

First quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.038 loss in 1Q 2022)

WELL Health Technologies Corp. Provides Earnings Guidance for the Year 2023

WELL Health Technologies Corp. Announces the Launch of Its Ground-Breaking Product, WELL AI Voice

WELL Health Technologies Corp. to Report Q1, 2023 Results on May 12, 2023

Full year 2022 earnings released: EPS: CA$0.006 (vs CA$0.23 loss in FY 2021)

Forecast to breakeven in 2024

Forecast to breakeven in 2024

Third quarter 2022 earnings released: CA$0.019 loss per share (vs CA$0.061 loss in 3Q 2021)

WELL Health Technologies Corp. Increases Annual Revenue Guidance for 2022

WELL Health Technologies Corp. to Report Q3, 2022 Results on Nov 10, 2022

Independent Director recently sold €267k worth of stock

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Cloud Practice Inc. and 3 Clinics from CloudMD Software & Services Inc. (TSXV:DOC) for CAD 5.75 million.

Independent Director recently sold €116k worth of stock

Second quarter 2022 earnings released: CA$0.027 loss per share (vs CA$0.08 loss in 2Q 2021)

WELL Health Technologies Corp. Updates Revenue Guidance for the Year of 2022

WELL Health Technologies Corp. Announces Appointment of Sybil Lau to its Board of Directors

WELL Health Technologies Corp. Provides Revenue Guidance for the Second Quarter 2022

WELL Appoints Iain Paterson to the Position of Chief Information Security Officer

WELL Health Technologies Corp. (TSX:WELL) entered into an asset purchase agreement to acquire Assets of INLIV Inc. from Coril Holdings Ltd. for CAD 1.8 million.

No longer forecast to breakeven

WELL Health Technologies Corp. has completed a Follow-on Equity Offering in the amount of $30.01107 million.

First quarter 2022 earnings released: CA$0.038 loss per share (vs CA$0.046 loss in 1Q 2021)

WELL Health Technologies Corp. Revises Earnings Guidance for the Year 2022

WELL Health Technologies Corp. to Report Q1, 2022 Results on May 12, 2022

Forecast breakeven date moved forward to 2022

WELL Health Technologies Corp. Provides Preliminary Earning Guidance for the First Quarter Ended March 31, 2022

WELL Health Technologies Corp., Annual General Meeting, Jun 17, 2022

Full year 2021 earnings released: CA$0.23 loss per share (vs CA$0.028 loss in FY 2020)

WELL Health Technologies Corp. Provides Earnings Guidance for the Year 2022

WELL Health Technologies Corp. (TSX:WELL) acquired CognisantMD for CAD 24.57 million.

Forecast to breakeven in 2023